about
Using national dietary intake data to evaluate and adapt the US Diet History Questionnaire: the stepwise tailoring of an FFQ for Canadian use.Adolescent dietary fiber, vegetable fat, vegetable protein, and nut intakes and breast cancer riskPhytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan.Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.Will Women Diagnosed with Breast Cancer Provide Biological Samples for Research Purposes?Self-Report Dietary Assessment Tools Used in Canadian Research: A Scoping Review.The Comparative Reliability and Feasibility of the Past-Year Canadian Diet History Questionnaire II: Comparison of the Paper and Web Versions.Fruit and vegetable intake and bone health in women aged 45 years and over: a systematic review.Dietary assessment is a critical element of health research - Perspective from the Partnership for Advancing Nutritional and Dietary Assessment in Canada.The Ontario Food and Nutrition Strategy: identifying indicators of food access and food literacy for early monitoring of the food environment.Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).Dietary phytoestrogens, including isoflavones, lignans, and coumestrol, in nonvitamin, nonmineral supplements commonly consumed by women in Canada.Effect of Current Dietary Recommendations on Weight Loss and Cardiovascular Risk Factors.Intake of phytoestrogen foods and supplements among women recently diagnosed with breast cancer in Ontario, Canada.Lecithin supplements and breast cancer risk.Use of isoflavone supplements is associated with reduced postmenopausal breast cancer riskPostdiagnosis Isoflavone and Lignan Intake in Newly Diagnosed Breast Cancer Patients: Cross-Sectional Survey Shows Considerable Intake from Previously Unassessed High-Lignan FoodsConsumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer riskHigh Coffee Intake, but Not Caffeine, is Associated with Reduced Estrogen Receptor Negative and Postmenopausal Breast Cancer Risk with No Effect Modification by CYP1A2 GenotypeDietary supplements, quality scores and missing data in the review of validation studiesHormone-related supplements and breast cancer risk: Need for improved measurement of supplement useSoy Formula and Breast Cancer RiskAdolescent dietary phytoestrogen intake and breast cancer risk (Canada)
P50
Q31110975-31BA4652-D481-4B44-81CE-55193E543492Q33836321-2FF0E4C2-B29F-47D8-A22F-6BE0F651B801Q33998405-85530A5A-9E9C-473F-B7CA-B9AD9EB02B2AQ34033220-B97463FA-FB6F-4843-8D74-31A0ABF49650Q35659578-6400B972-597C-4B6F-8895-FF9D7CD243C7Q36309675-E462E8F8-4927-4A51-9F1E-B32F6E03EF25Q37673205-B3E6BC12-EFEC-405E-B195-D368304E7A31Q37821789-21F1EF2D-5A2F-4B49-AA5A-C508B2648960Q40589743-189CDC77-B220-4B71-AEA3-D12F3A444E32Q43743843-393B423D-ECA2-4BF8-8708-BD8D04FF3191Q44294964-CC702165-D27F-468B-8437-08447C1CC6DFQ46900961-D67558AD-1045-4E03-8E55-B6BF2B9FC21BQ47231883-72F5B21F-9163-405A-9998-EFEF675D6F18Q50510105-4E5F30A8-DFC2-4249-A703-C918AB85EAAEQ54719977-AC554401-3AC9-46CB-8E6A-10DFFF9887D5Q56672310-33A5A442-1D5C-41EA-9728-C4669E8B0C5CQ58133554-C5981F17-6D87-4863-9B72-E107347CF1C6Q59150884-6A83168F-9B2F-402C-8766-96746EE6127DQ59150888-605D8DD6-54BC-4F0D-96FE-DDE1822B96D8Q59150893-FAEC5DAA-4C86-4760-BDDA-28FDD8474EA5Q59150896-01943BE7-451A-42D2-BF08-11DF2F6CE529Q59150898-9871386A-5BE1-447B-99B2-3203926B1B57Q59150901-7EFAF5EA-3497-492F-84EA-631593FA6CD8
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Beatrice A. Boucher
@ast
Beatrice A. Boucher
@en
Beatrice A. Boucher
@es
Beatrice A. Boucher
@nl
Beatrice A. Boucher
@sl
type
label
Beatrice A. Boucher
@ast
Beatrice A. Boucher
@en
Beatrice A. Boucher
@es
Beatrice A. Boucher
@nl
Beatrice A. Boucher
@sl
prefLabel
Beatrice A. Boucher
@ast
Beatrice A. Boucher
@en
Beatrice A. Boucher
@es
Beatrice A. Boucher
@nl
Beatrice A. Boucher
@sl
P106
P1153
12791492000
P21
P31
P496
0000-0001-6909-3792